103 related articles for article (PubMed ID: 11750936)
1. A vector system for introducing foreign HIV-1 env genes and pseudotyping of MuLV particles with the recombinant HIV-1 envelope proteins for anti-HIV-1 assay.
Lee MK; Seo JK; Kim HK; Cho JH; Poo H; Kim KL
Antiviral Res; 2002 Feb; 53(2):99-111. PubMed ID: 11750936
[TBL] [Abstract][Full Text] [Related]
2. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.
Höhne M; Thaler S; Dudda JC; Groner B; Schnierle BS
Virology; 1999 Aug; 261(1):70-8. PubMed ID: 10441556
[TBL] [Abstract][Full Text] [Related]
3. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells.
Schnierle BS; Stitz J; Bosch V; Nocken F; Merget-Millitzer H; Engelstädter M; Kurth R; Groner B; Cichutek K
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8640-5. PubMed ID: 9238030
[TBL] [Abstract][Full Text] [Related]
4. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins.
Lindemann D; Bock M; Schweizer M; Rethwilm A
J Virol; 1997 Jun; 71(6):4815-20. PubMed ID: 9151877
[TBL] [Abstract][Full Text] [Related]
5. Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors.
Christodoulopoulos I; Cannon PM
J Virol; 2001 May; 75(9):4129-38. PubMed ID: 11287562
[TBL] [Abstract][Full Text] [Related]
6. Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.
Song YE; Olinger GY; Janaka SK; Johnson MC
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894464
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins.
Morgan RA; Nussbaum O; Muenchau DD; Shu L; Couture L; Anderson WF
J Virol; 1993 Aug; 67(8):4712-21. PubMed ID: 8331726
[TBL] [Abstract][Full Text] [Related]
9. Directed evolution of retrovirus envelope protein cytoplasmic tails guided by functional incorporation into lentivirus particles.
Merten CA; Stitz J; Braun G; Poeschla EM; Cichutek K; Buchholz CJ
J Virol; 2005 Jan; 79(2):834-40. PubMed ID: 15613311
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.
Kiernan RE; Freed EO
J Virol; 1998 Dec; 72(12):9621-7. PubMed ID: 9811695
[TBL] [Abstract][Full Text] [Related]
11. Replacement of the murine leukemia virus (MLV) envelope gene with a truncated HIV envelope gene in MLV generates a virus with impaired replication capacity.
Nack U; Schnierle BS
Virology; 2003 Oct; 315(1):209-16. PubMed ID: 14592772
[TBL] [Abstract][Full Text] [Related]
12. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
Sandrin V; Muriaux D; Darlix JL; Cosset FL
J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
[TBL] [Abstract][Full Text] [Related]
13. Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response.
Quiñones-Kochs MI; Buonocore L; Rose JK
J Virol; 2002 May; 76(9):4199-211. PubMed ID: 11932385
[TBL] [Abstract][Full Text] [Related]
14. Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells.
Mammano F; Salvatori F; Indraccolo S; De Rossi A; Chieco-Bianchi L; Göttlinger HG
J Virol; 1997 Apr; 71(4):3341-5. PubMed ID: 9060707
[TBL] [Abstract][Full Text] [Related]
15. Molecular and phylogenetic analyses of a new amphotropic murine leukemia virus (MuLV-1313).
Howard TM; Sheng Z; Wang M; Wu Y; Rasheed S
Virol J; 2006 Dec; 3():101. PubMed ID: 17147829
[TBL] [Abstract][Full Text] [Related]
16. Analysis of HIV-1 envelope mutants and pseudotyping of replication-defective HIV-1 vectors by genetic complementation.
Delwart EL; Buchschacher GL; Freed EO; Panganiban AT
AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1669-77. PubMed ID: 1457211
[TBL] [Abstract][Full Text] [Related]
17. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.
Mammano F; Kondo E; Sodroski J; Bukovsky A; Göttlinger HG
J Virol; 1995 Jun; 69(6):3824-30. PubMed ID: 7745730
[TBL] [Abstract][Full Text] [Related]
18. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.
Tani Y; Tian H; Lane HC; Cohen DI
J Immunol; 1993 Dec; 151(12):7337-48. PubMed ID: 7903106
[TBL] [Abstract][Full Text] [Related]
19. Targeted infection of HIV-1 Env expressing cells by HIV(CD4/CXCR4) vectors reveals a potential new rationale for HIV-1 mediated down-modulation of CD4.
Ye Z; Harmison GG; Ragheb JA; Schubert M
Retrovirology; 2005 Dec; 2():80. PubMed ID: 16371160
[TBL] [Abstract][Full Text] [Related]
20. [Murine retrovirus vector expressing env gene of human immunodeficiency virus type 1 (HIV-1)].
Kimura T; Karn J
Uirusu; 1991 Dec; 41(2):85-94. PubMed ID: 1810088
[No Abstract] [Full Text] [Related]
[Next] [New Search]
